口服营养补充剂对营养不良老年人群体重增加的影响:一项开放标签随机对照试验
该研究为开放标签、随机对照、平行组设计,计划纳入50名居住在斯里兰卡科伦坡某养老机构的60岁以上营养不良或存在营养不良风险的老年人,按1:1随机分为干预组和对照组。干预组睡前连续12周饮用200 mL口服营养补充剂(ONS),主要结局为干预组较对照组达到至少5%体重增加的比例,同时评估营养状况、体成分、衰弱、功能能力、认知状态和体力活动等次要结局。
要点
- 研究对象为60岁以上、居住在养老机构且营养不良或存在营养不良风险的老年人,计划样本量50例。
- 干预组睡前连续12周饮用200 mL ONS,对照组为常规照护,主要结局为至少5%体重增加的比例。
- 次要结局涵盖营养状况、体成分(双能X线吸收法)、衰弱、功能能力、认知状态和体力活动,部分测量在第4周末进行。
核心结论
- 该研究将确定使用ONS是否有效促进营养不良或存在营养不良风险的老年人实现健康体重增加,并通过临床、营养、功能和认知等多方面结局全面了解ONS的潜在获益。
研究设计与样本
- 开放标签、随机对照、平行组研究,计划纳入50名居住在斯里兰卡科伦坡某养老机构的60岁以上营养不良或存在营养不良风险的老年人。
- 使用微型营养评估(MNA)工具筛查营养不良,采用简单随机抽样技术按1:1分配至干预组和对照组。
- 干预组睡前连续12周饮用200 mL ONS;主要结局为干预组较对照组达到至少5%体重增加的比例。
- 次要结局在基线和12周干预结束时评估营养状况(人体测量、生化、临床和膳食)、体成分(双能X线吸收法)、衰弱、功能能力(握力、膝关节伸展和Barthel指数)、认知状态(蒙特利尔认知评估)和体力活动;部分测量(人体测量、膳食和功能评估)也在第4周末进行。
- 数据使用SPSS V-23进行分析;试验注册号为斯里兰卡临床试验注册中心SLCTR/2022/021,注册日期2022年10月6日。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The global aging population is expanding rapidly and many individuals have a particularly higher risk of malnutrition. Malnutrition can lead to impaired body function, morbidity, and mortality. Meeting nutritional requirements is a key strategy to minimize multiple debilitating adverse outcomes associated with malnutrition in the elderly. Oral nutritional supplements (ONS) have been widely used as a dietary intervention for malnutrition in older adults. These supplements provide additional nutrients and calories to support nutritional requirements and have been shown to improve nutritional status, physical function, and quality of life in malnourished older adults. METHODS: This is an open-label, randomized controlled, parallel-group study including 50 institutionalized older adults (aged > 60 years) with malnutrition or at risk of malnutrition, living in a selected elderly care institution in Colombo, Sri Lanka. The aim is to assess improvement in healthy body weight gain and body composition in older adults with malnutrition at risk of malnutrition by using an ONS. Older adults will be screened for malnutrition using the Mini Nutrition Assessment (MNA) tool and eligible participants randomized using the simple random sampling technique to intervention and control groups (1:1 allocation ratio). The intervention group will consume 200 mL of ONS before bed continuously for 12 weeks. The primary outcome is the percentage who achieved at least 5% weight gain in the intervention group compared to the control group. Nutritional status (anthropometric, biochemical, clinical, and dietary), body composition (dual-energy X-ray absorptiometry), frailty, functional capacity (hand grip strength, knee extension, and Barthel index) cognitive status (Montreal Cognitive Assessment), and physical activity will be assessed as secondary outcomes at baseline and at the end of the 12-week intervention. Some measurements (anthropometry, dietary, and functional assessments) will also be performed at the end of the 4th week. Data will be analyzed using SPSS V-23. DISCUSSION: This study will determine whether the use of an ONS is effective in promoting healthy weight gain in older adults with malnutrition or at risk of malnutrition. In addition, investigating the impact of an ONS on multiple outcomes via clinical, nutritional, functional, and cognitive function will provide a more comprehensive understanding of the potential benefits of these supplements. TRIAL REGISTRATION: Sri Lanka Clinical Trail Registry SLCTR/2022/021. Oct. 6, 2022.
引用
- Jayawardena R, Wickramawardhane P, Dalpatadu C, et al. The impact of an oral nutritional supplement on body weight gain in older adults with malnutrition: an open-label randomized controlled trial. Trials. 2023. PMID: 37784119. doi:10.1186/s13063-023-07622-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。